| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-124126 |
| M.Wt: | 326.40 |
| Formula: | C22H18N2O |
| Purity: | >98 % |
| Solubility: |
NSC 1008 is a selective Ras converting enzyme 1 (Rce1) inhibitor that reduces Rce1 in vitro activity with a human IC50 of 8.9 μM. NSC 1008 demonstrates selectivity for Rce1 by not inhibiting human Ste24 or huamn FTase. NSC 1008 exhibits low cell toxicity, and induces mislocalization of EGFP-Ras from the plasma membrane in cancer cells. NSC 1008 can be used for the research of cancer[1].
In Vitro:NSC 1008 (compound 2) inhibits human Rce1 activity (IC50 = 8.9 μM)[1].
NSC 1008 (25 µM; 20 hours) exhibits low toxicity in HCT-116 cells[1].
NSC 1008 (25 µM; 20 hours) induces mislocalization of EGFP-H-Ras, EGFP-N-Ras, and EGFP-K-Ras4b in HCT-116 cells[1].
NSC 1008 (10-50 µM) demonstrates selectivity for Rce1 by not inhibiting human Ste24 or huamn FTase[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.